New Key Statistics Module, Z-Score and F-Score
OTCPK:AWKNF Key Ratios
Market Cap $ M | 4.67 |
Enterprise Value $ M | 4.15 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 1.61 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -0.18 |
Beneish M-Score | -18.32 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.61 |
EV-to-EBITDA | -0.66 |
PEG | -- |
Shares Outstanding M | 39.02 |
Net Margin (%) | -322.38 |
Operating Margin % | -452.18 |
Pre-tax Margin (%) | -434.71 |
Quick Ratio | 0.51 |
Current Ratio | 0.51 |
ROA % (ttm) | -199.75 |
ROE % (ttm) | -- |
ROIC % (ttm) | -368.39 |
Dividend Yield % | -- |
Altman Z-Score | -62.42 |
AWKNF Number of Guru Trades
AWKNF Volume of Guru Trades
Gurus Latest Trades with OTCPK:AWKNF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:AWKNF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Awakn Life Sciences Corp Insider Transactions
No Available Data
News about OTCPK:AWKNF
Total 0- 1